After being born two weeks ago to a mother who declined cancer treatment to save her baby's life, the baby has died.
Bismarck man sees success from new cancer treatment
The FDA approved Kymriah, which involves using genetically modified immune cells from patients to attack their cancer, to treat children and young adults up to age 25 suffering from a form of acute lymphoblastic leukemia who do not respond to standard ...
No comments:
Post a Comment